Pharma Capital
CompanyCurrentChange%Change
(COPL) 1.08 +0.35 +48.28%
(FRR) 0.38 +0.115 +44.23%
(AFN) 37.5 +6.5 +20.97%
(SVE) 3.75 +0.625 +20%
(UOG) 3.25 +0.5 +18.18%
(DRV) 60 +9 +17.65%
(PPS) 3.63 +0.5 +16%
(PPC) 8.38 +1.125 +15.52%
(JMAT) 3390 +432 +14.6%

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.